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Summary
Honey has been used as a wound dressing for hundreds of years by ancient civilizations, but only recently it has acquired 
scientific interest because of its relevant biological properties. In the last decade, indeed, several trials and observational 
studies have reported that, compared to conventional treatment (e.g. antiseptics, polyurethane film, paraffin gauze, 
soframycin-impregnated gauze), honey dressings seem to be better in healing time of different types of wounds, including 
diabetic foot ulcers. However, to date, information about a potential favorable biological effect of honey dressings 
on diabetic ulcers with exposed tendon are still scarce. Notably, foot or leg ulcers with exposed tendon are serious 
complications in patients with type 2 diabetes, as they are associated with an increased risk of adverse outcome. Therefore, 
the use of effective and safe treatments to bring these lesions to timely healing is very important in clinical practice. We 
herein report the case of a Caucasian adult patient with type 2 diabetes presenting a chronic right posterior lower limb 
ulcer (Texas University Classification (TUC) 2D) with tendon exposure that was successfully treated with honey dressings 
(glucose oxidase (GOX) positive with peroxide activity) in addition to systemic antibiotic therapy, surgical toilette and 
skin graft. In our case, the use of honey dressing for treating exposed tendon tissue probably allowed the timely wound 
healing. Although further studies are required, such treatment may constitute part of the comprehensive management of 
diabetic wounds, including those with tendon exposure, and should be considered by clinicians in clinical practice.
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Learning points:
 • Honey has been used as a wound dressing for hundreds of years, but only recently it has acquired scientific 
interest for its biological properties.
 • Several studies have documented that, compared to conventional dressings, honey seems to be better in healing 
time of different types of wounds, including diabetic foot ulcers.
 • Our case report is the first to highlight the importance to use honey dressings also for the treatment of ulcers with 
tendon exposure in patients with type 2 diabetes, suggesting that this kind of dressing should be considered by 
clinicians in clinical practice.
Introduction
Honey is a viscous, supersaturated sugar solution 
derived from nectar assembled and worked by 
honeybees (i.e., Apis mellifera), which contains 
approximately 40% of fructose, 30% of glucose, 20% 
of water and 5% of sucrose, as well as many bioactive 
substances, including amino acids, vitamins, minerals 
and enzymes (1, 2).
Honey has been used as a wound dressing for 
hundreds of years by numerous ancient civilizations, but 
only recently it has acquired scientific interest because 
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of its biological properties (for a detailed review on this 
topic please see 2). Indeed, it is established that honey 
is able to promote healing processes of wounds through 
multiple mechanisms (1, 2). For instance, several 
experimental studies have documented that the relative 
acidity of honey may help the deliverance of oxygen 
from hemoglobin, thus making the wound environment 
less advantageous to the bacterial growth (2). The high 
osmolarity of honey may even draw fluid out of the 
wound bed in order to promote an outflow of lymph as 
happens during negative pressure wound therapy (2). 
In addition, honey has an important broad-spectrum 
antibacterial activity, although there is difference in 
efficacy among specific honeys (2).
In the last decade, given the aforementioned 
biological properties of honey, several trials and 
observational studies have reported that, compared 
to other conventional treatment (e.g., antiseptics and 
gauze), honey dressings appear to be better in healing 
time of different wounds (2, 3, 4, 5, 6, 7). In addition, 
although apparently in a counter-intuitive manner, 
almost identical results were observed for foot ulcers in 
patients with type 2 diabetes (3, 4). However, to date, 
information regarding the potential favorable biological 
effects of honey dressings on ulcers with exposed tendon 
are still scarce, especially in those with type 2 diabetes 
mellitus. Importantly, foot or leg ulcers with exposed 
tendon are serious complications in such patients, as they 
are strongly associated with an increased risk of adverse 
outcome and even limb amputation (8). In this context, 
a retrospective observational study of nearly 400 patients 
with type 2 diabetes underwent surgical treatment 
for diabetic foot syndrome (8% of whom underwent 
immediate surgical debridement resulting in exposed 
tendon) shows the importance to cover an exposed and 
(still) healthy tendon as soon as possible, in order to avoid 
a rapid spread of infection and also preserving maximal 
residual foot length for future potential rehabilitation and 
mobility (9).
Given the multiple bioactivities of honey, although 
more information is at present required, it is reasonable 
to suppose that honey dressings may be effectively 
considered for the treatment of leg ulcers with exposed 
tendon in individuals with type 2 diabetes.
Thus, we herein report the case of a Caucasian adult 
patient with type 2 diabetes, presenting a chronic right 
posterior lower limb ulcer (Texas University Classification 
(TUC) 2D) with tendon exposure that was treated with 
honey dressings in addition to systemic antibiotic therapy, 
surgical toilette and skin graft.
Case presentation
A 79-year-old Caucasian male patient with type 2 
diabetes was admitted to our department for the 
worsening of a leg ulcer. The diagnosis of type 2 diabetes 
was made approximately 35 years ago and a treatment 
with insulin (lispro plus glargine) was initiated in 
2003. The glycemic compensation, however, was often 
poor (i.e., hemoglobin A1c was regularly more than 
60 mmol/mol Hb).
In addition to type 2 diabetes, his medical history 
included chronic kidney disease, hypertension, 
dyslipidemia, retinopathy, distal symmetric sensitive-
motor neuropathy and peripheral arteriopathy. The 
patient was not a smoker. To note, in 1975, the patient 
had a car crash that caused a right tibia and fibula 
fracture complicated by osteomyelitis followed by a 
subsequent limb deformity and skin chronic dystrophy.
The right posterior lower limb ulcer appeared 
in July 2017, following a domestic trauma, but the 
patient arrived in our Foot Clinic in November 2017, 
presenting a lesion of size of 62 × 51 mm with tendon 
exposure, mild perilesional redness and moderate 
exudate (Fig. 1, Panel A). Given the characteristics of 
the leg ulcer, we decided to perform a deep biopsy 
that revealed the presence of a polimicrobic infection, 
caused by methicillin-sensitive Staphylococcus aureus, 
Klebsiella oxytoca and Morganella morganii. Therefore, 
a systemic antibiotic therapy with piperacillina/
tazobactam was started.
Investigation
The blood tests revealed white blood cells (WBC): 
6.4 × 109/L (normal range: 4.3–10), hemoglobin: 136 g/L 
(normal range: 135–170), platelets: 196 × 100  000/
mm3 (normal range: 150–450), fasting plasma glucose: 
8.9 mmol/L (normal range: 3.5–5.5), hemoglobin 
A1c: 78 mmol/mol Hb (normal range: <42), alanine 
aminotransferase (ALT): 28 U/L (normal range: 6–50), 
gamma-glutamyl transpeptidase (GGT): 33 U/L (normal 
range: 4–60), creatinine: 136 µmol/L (normal range: 
53–115) and C-reactive protein (CRP): 24 mg/L (normal 
range: <5).
In addition, in order to complete the diagnostic–
therapeutic process, a lower limbs arteriosus 
ultrasonography confirmed the presence of serious 
peripheral arteriopathy that required an angioplasty of 
the right anterior tibial artery, which was performed 
with success.
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Treatment
During hospitalization, the clinical case was extensively 
discussed with the plastic surgeon and the infectivologist. 
The first suggested the execution of a surgical toilet 
followed by a skin graft in order to accelerate the healing, 
while the second indicated to continue the systemic 
antibiotic therapy with piperacillina/tazobactam for 
a total of 5–6  weeks. After the discharge, the skin graft 
adhesion was less than 50% and the tendon exposure 
persisted, but it was still vital (Fig. 1, Panel B).
Outcome and follow-up
In our ambulatory setting, we continued weekly soft 
mechanical debridement and conventional antiseptic 
dressings for at least 5 weeks without particular benefit; 
in other words, the ulcer was substantially the same size 
and the tendon was continuously exposed. Subsequently, 
given the impossibility of healing the lesion with this 
treatment, we decided to use a dressing based on honey 
and collagen (i.e., 60% collagen and 40% honey) on the 
top of the vital tendon and a 100% honey gel on the 
remaining lower limb ulcer with a weekly frequency. In 
this case, we used a positive glucose oxidase (GOX) with 
hydrogen peroxide activity (3‰). As covering dressing, 
we used sterile gauzes that were enough to handle the 
modest exudate produced weekly and following a weakly 
compressive bandage. The purpose of this treatment was 
to promote the migration of fibroblasts and other cells 
as well as to create a relatively acid pH environment that 
hampers the bacterial proliferation. A detailed elucidation 
of the honey dressing was given to the patient. His 
consent was obtained verbally. By contrast, the patient 
refused the proposal to use devices or pinstripe splints 
in order to reduce the supine pressure and the tendon 
sliding. During a period of approximately 8  weeks, 
more than half of the ulcer was completely epithelized 
and after another 10 weeks, the tendon was completely 
covered (Fig. 1, Panel C). The patient continued dressings 
with honey balm (composed by 50% of honey and 50% 
of beeswax) twice a week for further 4 weeks, in order to 
moisturize and soften the wound and the skin around 
(Fig. 1, Panels D and E).
Discussion
Honey is a low-cost topical dressing with important 
beneficial properties for the healing of wounds. Although 
honey was used as a wound dressing in the past, only 
recently it has re-acquired scientific interest because 
of its antimicrobial properties, anti-inflammatory and 
Panel A Panel B Panel C
Panel D Panel E
Figure 1
Leg ulcer with tendon exposure in a patient with type 2 diabetes. Panel A, initially the leg ulcer measured 62 × 51 mm and was characterized by tendon 
exposure, mild perilesional redness and moderate exudate. Panel B, after surgical toilette and the skin graft, the tendon exposure persisted, but it was 
still vital. Panels C, D and E, the use of honey dressing (glucose oxidase positive with peroxide activity) started to promote the re-epithelization of the 
tendon and the healing of the remaining ulcer. The complete healing of the lesion occurred after 3 months of treatment with the honey dressing.
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anti-oxidant activity and relevant nutritional contents 
(1, 2). In addition, recent experimental studies have 
clearly showed that the wound-healing properties of 
honey may also include the stimulation of tissue growth, 
the induction of re-epithelialization and the minimized 
scar formation (1, 2).
Our patient was a 79-year-old Caucasian male patient 
affected by type 2 diabetes presenting a leg infected 
ulcer with tendon exposure. The presence of an ulcer 
with tendon exposure in a patient with type 2 diabetes 
should be always considered with caution, as it is strongly 
associated with adverse outcomes (8, 9). Notably, the 
tendon was still vital. In our case, the systemic antibiotic 
therapy, the revascularization of lower limb arteries 
and the surgical toilette with skin graft have strongly 
contributed to the improvement of ulcer. However, all 
these treatments were not sufficient and decisive, as, 
after discharge, an ulcer of reduced size (about half of the 
initial one) with a part of the exposed tendon persisted 
again. At the beginning, in our ambulatory setting, we 
treated this lesion using conventional treatment (e.g., 
antiseptics) for several weeks, observing a slow and poor 
improvement (notably, a relative therapeutic inertia may 
be observed in this case). For this reason, we decided to 
change the dressing and to use a honey dressing, seeing 
a progressive re-epithelization of the tendon and the 
remaining leg ulcer. Given the improvement of the lesion 
through the honey dressing, it is possible to speculate that 
the significant re-epithelization of the lesion may have 
been determined by the specific biological properties 
of honey. Obviously, since this is merely a clinical 
case, we cannot draw any kind of conclusion, but only 
hypothesize that the antimicrobial, anti-inflammatory, 
anti-oxidant properties of honey, as well as its bioactive 
substances (of note, the honey dressing that we used was 
composed by a high concentration of enzymes, such as 
bee-defensin 1 (which has an antibacterial action) and 
glucose oxidase (which promotes the transformation 
of glucose into hydrogen peroxide, thus concurring to 
create an acidic milieu)), may have helped to create a 
favorable environment for the re-epithelization of tendon 
and healing of the remaining ulcer. This hypothesis is, 
however, supported by some recent evidence, suggesting 
that honey dressings may stimulate the immune response, 
suppress the local inflammation and bring about rapid 
autolytic debridement, thus promoting the growth of 
tissues for wound repair (1, 2, 3, 4, 5, 6). For instance, 
in a Cochrane systematic review, Jull et al. substantiated 
that honey dressings seemed to heal partial thickness 
burns more quickly than conventional treatment 
(i.e., polyurethane film, paraffin gauze, soframycin-
impregnated gauze, sterile linen and leaving the burns 
exposed), as well as infected post-operative wounds more 
swiftly than antiseptics and gauze (3). Additionally, in a 
randomized, controlled trial enrolling 348 type 2 diabetic 
patients with Wagner’s grade 1 and 2 ulcers randomized to 
honey dressing (n = 179) or normal saline dressing, Imran 
et al. reported that 136 wounds (75.9%) out of 179 were 
completely healed with honey dressing and 97 (57.4%) 
out of 169 with saline dressing (P < 0.01), thus suggesting 
that honey was an effective dressing agent instead of 
conventional dressings in treating diabetic patients with 
foot ulcer (4).
In conclusion, our case report is clinically relevant, 
as it highlights the use of honey dressing (as a possible 
alternative to currently available, often expensive, 
dressings) in a leg ulcer with exposure of tendon in a 
patient with type 2 diabetes. Seen that honey includes 
multiple bioactive molecules, clinicians may consider this 
kind of dressing in their daily choices of local therapy, also 
in the presence of tendon exposure. In this case, in fact, 
it is really important to maintain the moisture balance, 
especially at the level of the tendon and, at the same time, 
to avoid contamination and infection that may extent 
along the tendon and respective compartment, thus 
worsening the prognosis.
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